Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients

This study has been completed.
Information provided by:
AMAG Pharmaceuticals, Inc. Identifier:
First received: November 17, 2005
Last updated: January 7, 2015
Last verified: October 2008